Literature DB >> 11238058

Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.

M Zareie1, P K Singh, E J Irvine, P M Sherman, D M McKay, M H Perdue.   

Abstract

Intestinal immune cells are less reactive than those in the peripheral blood; however, such cells from patients with Crohn's disease may be more responsive to bacterial products. Our study examined if nonpathogenic bacteria or lipopolysaccharide (LPS), can affect epithelial function in the presence of monocytes/macrophages. Lamina propria mononuclear cells (LPMCs) and peripheral blood monocytes (PBMs) were obtained from patients with Crohn's disease and control patients. Filter-grown T84 epithelial monolayers were co-cultured with nonactivated or LPS-activated LPMCs or PBMs for 48 hours. Epithelial secretory [baseline short-circuit current (Isc) and DeltaIsc to forskolin] and barrier (transepithelial electrical resistance) parameters were measured in Ussing chambers. LPS-activated PBMs from both controls and patients with Crohn's disease significantly increased Isc ( approximately 300%) and reduced transepithelial electrical resistance ( approximately 40%). Epithelial function was not altered after co-culture with control LPMCs +/- LPS. However, LPMCs from patients with Crohn's disease spontaneously secreted tumor necrosis factor-alpha, and induced epithelial changes similar to those produced by LPS-activated PBMs. Co-culture with control Escherichia coli and PBMs induced comparable changes in epithelial physiology, which were abrogated by anti-tumor necrosis factor-alpha antibody. We conclude that LPMCs of patients with Crohn's disease are spontaneously activated, possibly by gram-negative luminal bacteria, and can directly cause significant alterations in epithelial ion transport and barrier functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238058      PMCID: PMC1850371          DOI: 10.1016/S0002-9440(10)64057-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.

Authors:  N V Contractor; H Bassiri; T Reya; A Y Park; D C Baumgart; M A Wasik; S G Emerson; S R Carding
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 3.  Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease.

Authors:  J Rugtveit; E M Nilsen; A Bakka; H Carlsen; P Brandtzaeg; H Scott
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

4.  Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions.

Authors:  D J Philpott; D M McKay; P M Sherman; M H Perdue
Journal:  Am J Physiol       Date:  1996-04

5.  T cell-monocyte interactions regulate epithelial physiology in a coculture model of inflammation.

Authors:  D M McKay; K Croitoru; M H Perdue
Journal:  Am J Physiol       Date:  1996-02

6.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

8.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

Authors:  L Dianda; A M Hanby; N A Wright; A Sebesteny; A C Hayday; M J Owen
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

9.  Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

Authors:  J M Reimund; C Wittersheim; S Dumont; C D Muller; J S Kenney; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

10.  Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.

Authors:  G Bouma; M Oudkerk Pool; J G Scharenberg; J J Kolkman; B M von Blomberg; R J Scheper; S G Meuwissen; A S Peña
Journal:  Scand J Gastroenterol       Date:  1995-11       Impact factor: 2.423

View more
  21 in total

1.  Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

Authors:  D Faust; K Raschke; S Hormann; V Milovic; J Stein
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon.

Authors:  D Berrebi; R Maudinas; J-P Hugot; M Chamaillard; F Chareyre; P De Lagausie; C Yang; P Desreumaux; M Giovannini; J-P Cézard; H Zouali; D Emilie; M Peuchmaur
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

3.  Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.

Authors:  S Dionne; S Laberge; C Deslandres; E G Seidman
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

4.  Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.

Authors:  Aisha Nazli; Arthur Wang; Oren Steen; David Prescott; Jun Lu; Mary H Perdue; Johan D Söderholm; Philip M Sherman; Derek M McKay
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients.

Authors:  Q S Guo; B Xia; Y Jiang; S A Morré; L Cheng; J Li; J B A Crusius; A S Peña
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

Review 7.  Intestinal inflammation and the diet: Is food friend or foe?

Authors:  Bryant W Megna; Patrick R Carney; Gregory D Kennedy
Journal:  World J Gastrointest Surg       Date:  2016-02-27

8.  Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice.

Authors:  Shao-Xuan Wang; Wan-Chun Wu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 9.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.

Authors:  Akira Sakata; Takashi Ochiai; Hiroshi Shimeno; Sadao Hikishima; Tsutomu Yokomatsu; Shiroshi Shibuya; Akihisa Toda; Reiko Eyanagi; Shinji Soeda
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.